News & Updates
Filter by Specialty:
Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage
Clinical outcomes within 1 year of MR-guided stereotactic body radiation therapy (MRgSBRT) with rectal spacer for patients with localized prostate cancer (PC) show excellent tolerability, minimal gastrointestinal (GI) toxicity as well as improved rectal sparing and target coverage vs a non-spacer comparison cohort.
Rectal spacers in MR-guided SBRT for localized prostate cancer very well tolerated, improve rectal sparing and target coverage
20 Mar 2024Antidepressants improve cognition in people with late-life depression
Use of antidepressant medication may lead to improvements in some areas of cognitive function, such as memory and learning, in individuals with late-life depression (LLD), a study has shown.
Antidepressants improve cognition in people with late-life depression
19 Mar 2024Dupilumab mends skin barrier in children with AD, but with caveat
Use of dupilumab results in normalization of stratum corneum (SC) lipids, which is responsible for skin barrier function, in children with atopic dermatitis (AD) within 1 to 2 months of treatment, according to a study presented at AAAAI 2024.
Dupilumab mends skin barrier in children with AD, but with caveat
19 Mar 2024Bright light therapy of no benefit in teens with moderate or severe depression
In the treatment of adolescents with moderate or severe major depressive disorder, adding bright light therapy to psychiatric inpatient treatment as usual falls short of significantly reducing depressive symptoms when compared with placebo, as shown in a study.
Bright light therapy of no benefit in teens with moderate or severe depression
19 Mar 2024Stopping TDF prophylaxis immediately postpartum feasible in highly viraemic CHB mothers
In highly viraemic pregnant women with chronic hepatitis B (CHB), stopping peripartum prophylaxis (PP) with tenofovir disoproxil fumarate (TDF) immediately after delivery does not increase the risk of relapse or retreatment vs TDF cessation at ≥4 weeks postpartum. Early withdrawal of PP-TDF, combined with standard neonatal immunization schemes, is 100 percent effective in preventing mother-to-child transmission (MTCT).